Skip to main content

Table 3 CPSP following MIA

From: Chronic postsurgical pain after minimally invasive adrenalectomy: prevalence and impact on quality of life

Parameters

Univariate analysis OR (95% CI)

p-value

Multivariate analysis OR (95% CI)

p-value

Age at time of surgery

0.973 (0.950–0.998)

.033

0.957 (0.930–0.983)

.002

Gender (male)

0.576 (0.311–1.067)

.080

BMI (kg m−2)

1.069 (1.006–1.137)

.031

1.050 (0.984–1.121)

.139

ASA-score

2.031 (1.099–3.751)

.024

1.922 (0.955–3.871)

.067

Diabetes

0.726 (0.292–1.806)

.490

  

Preoperative pain

2.121 (1.015–4.434

.046

1.607 (0.675–3.828)

.284

Preoperative neurological disease

0.965 (0.485–1.917)

.918

  

History of abdominal surgery

1.522 (0.811–2.856)

.191

  

Side of adrenalectomy (left)

1.659 (0.863–3.189)

.129

  

Type of procedure (retroperitoneal)

0.432 (0.225–0.828)

.011

1.886 (0.941–3.779)

.074

Indication of adrenalectomy

 Primary aldosteronism

0.529 (0.283–0.990)

.046

0.637 (0.317–1.280)

.205

 Pheochromocytoma

1.808 (0.932–3.507)

.080

  

 Cushing syndrome

1.360 (0.589–3.139)

.471

  

 Other

1.026 (0.430–2.445)

.954

  

Duration of surgery (d)

1.003 (0.997–1.010)

.363

 

Postoperative complications:

 Clavien-Dindo I

1.451 (0.394–5.342)

.576

  

 Clavien-Dindo II

2.209 (0.565–8.635)

.254

  

 Clavien-Dindo III

6.111 (1.475–25.315)

.013

3.091 (0.650–14.711)

.156

  1. Significant p-values are in bold
  2. ASA American Society of Anesthesiologists, d days, MIA Minimally invasive adrenalectomy, OR Odds ratio, PA Primary aldosteronism, y years, 95% CI 95% confidence interval